0001209191-20-052246.txt : 20200928
0001209191-20-052246.hdr.sgml : 20200928
20200928175521
ACCESSION NUMBER: 0001209191-20-052246
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200925
FILED AS OF DATE: 20200928
DATE AS OF CHANGE: 20200928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hallam Trevor
CENTRAL INDEX KEY: 0001326592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 201205489
MAIL ADDRESS:
STREET 1: PALATIN TECHNOLOGIES, INC.
STREET 2: 4C CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 310 UTAH AVE., SUITE 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 310 UTAH AVE., SUITE 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: SUTRO BIOPHARMA INC
DATE OF NAME CHANGE: 20061127
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-25
0
0001382101
SUTRO BIOPHARMA, INC.
STRO
0001326592
Hallam Trevor
C/O SUTRO BIOPHARMA, INC.
310 UTAH AVENUE, SUITE 150
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Common Stock
2020-09-25
4
M
0
11019
0.00
A
27809
D
Common Stock
2020-09-25
4
F
0
3810
10.30
D
23999
D
Common Stock
2020-09-25
4
M
0
6887
0.00
A
30886
D
Common Stock
2020-09-25
4
F
0
2381
10.30
D
28505
D
Common Stock
2020-09-28
4
S
0
975
10.2633
D
27530
D
Restricted Stock Unit (RSU)
2020-09-25
4
M
0
11019
0.00
D
2021-09-26
Common Stock
11019
11019
D
Restricted Stock Unit (RSU)
2020-09-25
4
M
0
6887
0.00
D
2020-09-26
Common Stock
6887
0
D
Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.16 to $10.41 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date.
The RSUs vest as to 1/2 of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date.
/s/ Edward C. Albini as attorney-in-fact for Trevor Hallam
2020-09-28